RP101 - Medicine for the Prevention of Chemoresistance

Latest News
RP101 Mode Of Action Elucidated: Heat Shock Protein Hsp27 Enrollment In Phase 2 Clinical Trial Completed Gewinner des BMWi-Wettbewerbs THESEUS MITTELSTAND stehen fest European Venture Contest Award 2008 STEP Award 2008 Los Angeles Award 2008

RP101 related Publications
Targeted Drug Therapy in Pancreatic Cancer Proteomics finding heat shock protein 27 Anti-Cancer Therapeutic Approaches RP101 improves the efficacy of chemotherapy Protein Profiling of Microdissected Pancreas Carcinoma

Home

RESprotect GmbH

	+49 351 / 450 32 00
	+49 351 / 450 32 10

Send an Email to this Contact: